Published in Ann Intern Med on April 01, 1973
Immunity to Candida albicans. Microbiol Rev (1980) 1.66
Neutrophil chemotaxis dysfunction in human periodontitis. Infect Immun (1980) 1.48
Functions of phagocytic cells in chronic mucocutaneous candidiasis. Br Med J (1978) 1.37
Effects of levamisole on normal and abnormal leukocyte locomotion. J Clin Invest (1977) 1.23
Immunoglobulins in the hyperimmunoglobulin E and recurrent infection (Job's) syndrome. Deficiency of anti-Staphylococcus aureus immunoglobulin A. J Clin Invest (1985) 1.11
Defective neutrophil chemotaxis and raised serum ige levels in a child with recurrent bacterial infections and eczema. Influence of levamisole. Arch Dis Child (1978) 1.11
Surface receptors on neutrophils and monocytes from immunodeficient and normal horses. Immunology (1975) 1.10
Mononuclear cells from patients with the hyperimmunoglobulin E-recurrent infection syndrome produce an inhibitor of leukocyte chemotaxis. J Clin Invest (1982) 1.00
Ketoconazole, amphotericin B, and amphotericin B methyl ester: comparative in vitro and in vivo toxicological effects on neutrophil function. Antimicrob Agents Chemother (1981) 0.98
Clinical conditions associated with defective polymorphonuclear leukocyte chemotaxis. Am J Pathol (1977) 0.95
Staphylococcal infections in childhood dermatomyositis--association with the development of calcinosis, raised IgE concentrations and granulocyte chemotactic defect. Ann Rheum Dis (1992) 0.84
Identification of an IgA inhibitor of neutrophil chemotaxis and its membrane target for the metabolic burst. Immunology (1990) 0.81
Defective neutrophil motility and recurrent infection. In vitro and in vivo effects of levamisole. Clin Exp Immunol (1978) 0.80
Defective neutrophil chemotaxis in bone marrow transplant patients. J Clin Invest (1976) 0.80
Transfer factor therapy in hyperimmunoglobulinaemia E syndrome. Clin Exp Immunol (1979) 0.75
Cutaneous wound healing. N Engl J Med (1999) 19.12
Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science (1994) 12.83
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS (2001) 8.89
H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors. J Clin Invest (1975) 5.90
Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Biol (1983) 5.73
Hydrogen peroxide release from mouse peritoneal macrophages: dependence on sequential activation and triggering. J Exp Med (1977) 5.44
Granulocyte chemotaxis: an improved in vitro assay employing 51 Cr-labeled granulocytes. J Immunol (1973) 4.61
Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med (1971) 4.41
Clinical problem-solving. Decision making by analogy. N Engl J Med (1995) 4.23
Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. J Infect Dis (1972) 3.75
Future roles and training of internal medicine subspecialists. American Board of Internal Medicine Task Force on Subspecialty Internal Medicine. Ann Intern Med (1996) 3.70
Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes. J Clin Invest (1972) 3.69
Defective granulocyte chemotaxis in the Chediak-Higashi syndrome. J Clin Invest (1971) 3.58
Structural analysis of human neutrophil migration. Centriole, microtubule, and microfilament orientation and function during chemotaxis. J Cell Biol (1977) 3.33
The microbicidal mechanisms of human neutrophils and eosinophils. Rev Infect Dis (1981) 3.29
Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci U S A (1999) 3.21
Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src. Science (1990) 3.15
Angiogenesis in wound healing. J Investig Dermatol Symp Proc (2000) 3.12
Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes (1974) 2.77
Controlled trial of an audit facilitator in diagnosis and treatment of childhood asthma in general practice. BMJ (1995) 2.77
Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism. N Engl J Med (1995) 2.74
The mini-CEX (clinical evaluation exercise): a preliminary investigation. Ann Intern Med (1995) 2.72
H2O2 release from human granulocytes during phagocytosis. Relationship to superoxide anion formation and cellular catabolism of H2O2: studies with normal and cytochalasin B-treated cells. J Clin Invest (1977) 2.71
Immunology of the mycoses. I. Depressed lymphocyte transformation in chronic histoplasmosis. J Immunol (1968) 2.59
Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways. Clin Immunol Immunopathol (1975) 2.56
Neutrophil-mediated tumor cell cytotoxicity: role of the peroxidase system. J Exp Med (1975) 2.56
Separation and characterization of human neutrophil granules. Am J Pathol (1974) 2.50
Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase. Proc Natl Acad Sci U S A (1989) 2.49
Bactericidal and opsonic properties of C4-deficient guinea pig serum. J Immunol (1972) 2.48
The selective eosinophil chemotactic activity of histamine. J Exp Med (1975) 2.45
Iodination by human polymorphonuclear leukocytes: a re-evaluation. J Lab Clin Med (1977) 2.45
Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558. J Clin Invest (1991) 2.38
Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci U S A (2001) 2.35
Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. Am J Med (1983) 2.35
Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med (1981) 2.31
Fibronectin fragment(s) are chemotactic for human peripheral blood monocytes. J Immunol (1982) 2.29
Myeloperoxidase-mediated iodination by granulocytes. Intracellular site of operation and some regulating factors. J Clin Invest (1974) 2.28
Peroxidase-H2O2-halide system: Cytotoxic effect on mammalian tumor cells. Blood (1975) 2.25
Studies on the origin of human leukocytic pyrogen. J Exp Med (1970) 2.22
Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease. Science (1988) 2.21
What determines levels of passive smoking in children with asthma? Thorax (1997) 2.20
Wound repair in the context of extracellular matrix. Curr Opin Cell Biol (1994) 2.14
Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial. Ann Intern Med (1980) 2.14
Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Cell Biol (1990) 2.12
Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol (1982) 2.10
Teaching compassion and respect. Attending physicians' responses to problematic behaviors. J Gen Intern Med (1999) 2.10
Does passive smoking increase the frequency of health service contacts in children with asthma? Thorax (2001) 2.04
Treatment of ventricular arrhythmias with mexiletine (Kö 1173). Lancet (1973) 2.04
Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med (1998) 2.01
In vivo co-distribution of fibronectin and actin fibers in granulation tissue: immunofluorescence and electron microscope studies of the fibronexus at the myofibroblast surface. J Cell Biol (1984) 1.99
Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro. Infect Immun (1982) 1.99
Studies on the mechanism of antibody-dependent polymorphonuclear leukocyte-mediated cytotoxicity. J Immunol (1977) 1.98
Phagocytosis in chronic granulomatous disease and the Chediak-Higashi syndrome. N Engl J Med (1972) 1.96
The immunology of mycobacterial diseases. Am Rev Respir Dis (1986) 1.96
Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study. Arch Intern Med (1995) 1.95
Observations on the structure, process and clinical outcomes of asthma care in general practice. Br J Gen Pract (1996) 1.94
Assembly of the neutrophil respiratory burst oxidase. Protein kinase C promotes cytoskeletal and membrane association of cytosolic oxidase components. J Biol Chem (1991) 1.92
The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood (1980) 1.91
Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro. J Clin Invest (1980) 1.89
Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol (1989) 1.88
Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Morphologic and functional studies. Ann Intern Med (1974) 1.87
Cutaneous tissue repair: basic biologic considerations. I. J Am Acad Dermatol (1985) 1.86
Factors affecting the quantitative production and assay of human leukocytic pyrogen. J Lab Clin Med (1970) 1.86
Relationships between the rate of synthesis of ATP and the concentrations of reactants and products of ATP hydrolysis in maize root tips, determined by 31P nuclear magnetic resonance. Arch Biochem Biophys (1985) 1.78
Role of the myeloperoxidase-H2O2-halide system in concanavalin A-induced tumor cell killing by human neutrophils. J Immunol (1979) 1.77
Interactions between antibiotics and human neutrophils in the killing of staphylococci. J Clin Invest (1981) 1.74
Characterization of an IgA rheumatoid factor: finding properties and reactivity with the subclasses of human G globulin. Immunochemistry (1972) 1.73
Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol (1985) 1.72
Role of myeloperoxidase in the respiratory burst of human neutrophils. Blood (1983) 1.71
Calreticulin functions as a molecular chaperone in the biosynthesis of myeloperoxidase. J Biol Chem (1995) 1.69
Certification and specialization: do they matter in the outcome of acute myocardial infarction? Acad Med (2000) 1.68
Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J Cell Sci (1997) 1.67
Simultaneous characterization of free Candida antigens and Candida precipitins in a patient's serum by means of crossed immunoelectrophoresis with intermidiate gel. J Immunol Methods (1973) 1.67
Credentials misrepresentation: another challenge to professionalism. Ann Intern Med (1995) 1.67
NADPH oxidase of human neutrophils. Subcellular localization and characterization of an arachidonate-activatable superoxide-generating system. J Biol Chem (1987) 1.66
Myeloperoxidase-catalyzed inactivation of alpha 1-protease inhibitor by human neutrophils. J Biol Chem (1981) 1.65
Leukocytic function in hypogammaglobulinemia. J Clin Invest (1970) 1.65
Preoperative evaluation of patients for liver resection. Appropriate CT imaging. Ann Surg (1993) 1.65
Studies on the effect of experimental nonketotic diabetes mellitus on antibacterial defense. I. Demonstration of a defect in phagocytosis. J Exp Med (1966) 1.60
Infective endocarditis: a survey of cases in the South-East region of Scotland, 1969-72. Thorax (1976) 1.59
Myeloperoxidase deficiency: prevalence and clinical significance. Ann Intern Med (1981) 1.58
Advising parents of asthmatic children on passive smoking: randomised controlled trial. BMJ (1999) 1.57
Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses. Lancet (1974) 1.56
Hemolysis and iodination of erythrocyte components by a myeloperoxidase-mediated system. Blood (1975) 1.56
Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system. J Immunol (1987) 1.55
Effect of transfer factor on lymphocyte function in anergic patients. J Clin Invest (1972) 1.52
Advanced achievement in internal medicine: the end of the line for voluntary recertification. J Gen Intern Med (1990) 1.52
A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med (1977) 1.51
The myeloperoxidase-hydrogen peroxide-halide system as effector of neutrophil-mediated tumor cell cytotoxicity. J Immunol (1981) 1.47
Lactoferrin--specific localization in the nuclei of human polymorphonuclear neutrophilic leukocytes. Proc Soc Exp Biol Med (1971) 1.47
Certification in internal medicine: 1989-1992. J Gen Intern Med (1994) 1.46
Myeloperoxidase--H2O2--halide system: cytotoxic effect on human blood leukocytes. Blood (1977) 1.45
Chronic mucocutaneous moniliasis with impaired delayed hypersensitivity. Clin Exp Immunol (1970) 1.45
Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: relation to host-defense mechanisms in chronic mucocutaneous candidiasis. J Infect Dis (1971) 1.43
Fibronectin in delayed-type hypersensitivity skin reactions: associations with vessel permeability and endothelial cell activation. J Immunol (1981) 1.42
Progressive immunodeficiency in a patient with IgA deficiency. Ann Allergy Asthma Immunol (1997) 1.41
Redistribution of intracellular Ca2+ stores during phagocytosis in human neutrophils. Science (1994) 1.39
Screening mammography in the Tampa Bay area: current status and implications for the next decade. J Fla Med Assoc (1989) 1.39